Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Development of a stable reference material for prostatic acid phosphatase.

P H Duncan, R L Van Etten, M L MacNeil

    Clinical Chemistry
    |August 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Editorial: How Will Aducanumab Approval Impact AD Research?

    The journal of prevention of Alzheimer's disease·2021
    Same author

    Postoperative pulmonary complications following major head and neck cancer surgery.

    International journal of oral and maxillofacial surgery·2020
    Same author

    Beclin 1 regulates growth factor receptor signaling in breast cancer.

    Oncogene·2015
    Same author

    FASTKD2 is associated with memory and hippocampal structure in older adults.

    Molecular psychiatry·2014
    Same author

    Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals.

    Translational psychiatry·2014
    Same author

    CSF protein biomarkers predicting longitudinal reduction of CSF β-amyloid42 in cognitively healthy elders.

    Translational psychiatry·2013
    Same journal

    Interlaboratory Comparison of a Glucagon and Oxyntomodulin Immuno-LC-MS/MS Assay: Implications for Diabetes Research.

    Clinical chemistry·2026
    Same journal

    Comparison of Information-Dependent Acquisition and Sequential Window Acquisition of All Theoretical Mass Spectra for Untargeted Drug Testing on a Linear Ion Trap-Pulsing Quadrupole-Time of Flight Mass Spectrometer.

    Clinical chemistry·2026
    Same journal

    Patterns of One-Year Change in HbA1c and Continuous Glucose Monitoring (CGM) Metrics in Older Adults with Type 2 Diabetes.

    Clinical chemistry·2026
    Same journal

    TSH Pediatric Reference Intervals: Lack of CALIPER Applicability to US-Based Populations.

    Clinical chemistry·2026
    Same journal

    Rapid Detection of Hemoglobinopathy Variants Using One-Step Library Preparation and Nanopore Sequencing.

    Clinical chemistry·2026
    Same journal

    Editor's Note: Circulating Proteolytic Products of Carboxypeptidase N for Early Detection of Breast Cancer.

    Clinical chemistry·2026
    See all related articles

    Stable reference materials for prostatic acid phosphatase (PAP) were developed from human sources. These purified enzyme preparations demonstrate satisfactory stability for use in clinical diagnostics and reference method development.

    Area of Science:

    • Biochemistry
    • Clinical Chemistry
    • Enzymology

    Background:

    • Prostatic acid phosphatase (PAP) is a key biomarker for prostate cancer.
    • Standardized reference materials are crucial for accurate clinical diagnostic assays.

    Purpose of the Study:

    • To develop a stable reference material for prostatic acid phosphatase (PAP).
    • To ensure the reliability and consistency of PAP measurements in clinical settings.

    Main Methods:

    • Purification of PAP from human prostatic tissue and seminal fluid using L-tartramic acid affinity chromatography.
    • Assessment of purity using two-dimensional electrophoresis and specific enzyme tests.
    • Evaluation of stability (catalytic activity and immunological identity) in a human serum albumin matrix.

    Related Experiment Videos

    Main Results:

    • Highly purified PAP preparations were successfully obtained from both human prostatic tissue and seminal fluid.
    • Electrophoresis and enzyme tests confirmed the absence of significant protein and enzyme contaminants.
    • The reference material demonstrated satisfactory stability in terms of both enzymatic activity and immunological properties.

    Conclusions:

    • The developed prostatic acid phosphatase reference material is stable and suitable for use.
    • These preparations are acceptable for developing clinical reference methods and diagnostic kits.
    • This advancement supports improved accuracy and standardization in prostate cancer diagnostics.